3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      A review of the application of machine learning in molecular imaging

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Molecular imaging (MI) is a science that uses imaging methods to reflect the changes of molecular level in living state and conduct qualitative and quantitative studies on its biological behaviors in imaging. Optical molecular imaging (OMI) and nuclear medical imaging are two key research fields of MI. OMI technology refers to the optical information generated by the imaging target (such as tumors) due to drug intervention and other reasons. By collecting the optical information, researchers can track the motion trajectory of the imaging target at the molecular level. Owing to its high specificity and sensitivity, OMI has been widely used in preclinical research and clinical surgery. Nuclear medical imaging mainly detects ionizing radiation emitted by radioactive substances. It can provide molecular information for early diagnosis, effective treatment and basic research of diseases, which has become one of the frontiers and hot topics in the field of medicine in the world today. Both OMI and nuclear medical imaging technology require a lot of data processing and analysis. In recent years, artificial intelligence technology, especially neural network-based machine learning (ML) technology, has been widely used in MI because of its powerful data processing capability. It provides a feasible strategy to deal with large and complex data for the requirement of MI. In this review, we will focus on the applications of ML methods in OMI and nuclear medical imaging.

          Related collections

          Most cited references158

          • Record: found
          • Abstract: found
          • Article: not found

          Deep learning.

          Deep learning allows computational models that are composed of multiple processing layers to learn representations of data with multiple levels of abstraction. These methods have dramatically improved the state-of-the-art in speech recognition, visual object recognition, object detection and many other domains such as drug discovery and genomics. Deep learning discovers intricate structure in large data sets by using the backpropagation algorithm to indicate how a machine should change its internal parameters that are used to compute the representation in each layer from the representation in the previous layer. Deep convolutional nets have brought about breakthroughs in processing images, video, speech and audio, whereas recurrent nets have shone light on sequential data such as text and speech.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Mild cognitive impairment as a diagnostic entity.

            The concept of cognitive impairment intervening between normal ageing and very early dementia has been in the literature for many years. Recently, the construct of mild cognitive impairment (MCI) has been proposed to designate an early, but abnormal, state of cognitive impairment. MCI has generated a great deal of research from both clinical and research perspectives. Numerous epidemiological studies have documented the accelerated rate of progression to dementia and Alzheimer's disease (AD) in MCI subjects and certain predictor variables appear valid. However, there has been controversy regarding the precise definition of the concept and its implementation in various clinical settings. Clinical subtypes of MCI have been proposed to broaden the concept and include prodromal forms of a variety of dementias. It is suggested that the diagnosis of MCI can be made in a fashion similar to the clinical diagnoses of dementia and AD. An algorithm is presented to assist the clinician in identifying subjects and subclassifying them into the various types of MCI. By refining the criteria for MCI, clinical trials can be designed with appropriate inclusion and exclusion restrictions to allow for the investigation of therapeutics tailored for specific targets and populations.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Diagnosis and Treatment of Parkinson Disease: A Review

              Parkinson disease is the most common form of parkinsonism, a group of neurological disorders with Parkinson disease-like movement problems such as rigidity, slowness, and tremor. More than 6 million individuals worldwide have Parkinson disease.
                Bookmark

                Author and article information

                Journal
                Ann Transl Med
                Ann Transl Med
                ATM
                Annals of Translational Medicine
                AME Publishing Company
                2305-5839
                2305-5847
                May 2021
                May 2021
                : 9
                : 9
                : 825
                Affiliations
                [1 ]deptKey Laboratory of Molecular Imaging of Chinese Academy of Sciences, Institute of Automation , Chinese Academy of Sciences , Beijing, China;
                [2 ]deptSchool of Artificial Intelligence , University of Chinese Academy of Sciences , Beijing, China;
                [3 ]Peking University First Hospital , Beijing, China;
                [4 ]deptBeijing Advanced Innovation Center for Big Data-Based Precision Medicine , Beihang University , Beijing, China
                Author notes

                Contributions: (I) Conception and design: L Yin, Z Cao, K Wang; (II) Administrative support: X Yang, J Tian; (III) Provision of study materials or patients: X Yang, J Zhang; (IV) Collection and assembly of data: K Wang, J Zhang, J Tian; (V) Data analysis and interpretation: L Yin, Z Cao; (VI) Manuscript writing: All authors; (VI) Manuscript writing: All authors.

                [#]

                These authors contributed equally to this work.

                Correspondence to: Jie Tian. No. 95 Zhongguancun East Road, Haidian District, Beijing 100190, China. Email: tian@ 123456ieee.org ; Xing Yang. No. 8 Xishiku Street, Xicheng District, Beijing, China. Email: yangxing2017@ 123456bjmu.edu.cn ; Jianhua Zhang. No. 8 Xishiku Street, Xicheng District, Beijing, China. Email: zjhjn820@ 123456163.com .
                Article
                atm-09-09-825
                10.21037/atm-20-5877
                8246214
                34268438
                e695f475-f2f1-4e27-87ad-ec8f5b74f21d
                2021 Annals of Translational Medicine. All rights reserved.

                Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0.

                History
                : 16 April 2020
                : 02 October 2020
                Categories
                Review Article on Artificial Intelligence in Molecular Imaging

                molecular imaging (mi),optical molecular imaging (omi),nuclear medical imaging,artificial intelligence

                Comments

                Comment on this article